Searched for
RANBAXY
SC draws the line on Fortis audit, says no ‘fishing and roving’ probe into banksThe Supreme Court clarified the forensic audit's focus is on Fortis Healthcare Holdings Private Limited and the Singh Brothers. This audit ...- SC clears forensic audit of Fortis-IHH deal involving erstwhile Religare promoters Singh brothersThe Supreme Court has cleared the way for a Delhi High Court-appointed forensic auditor to examine transactions involving Fortis Healthcare...
- Supreme Court backs Delhi HC orders in Daiichi-Fortis dispute, clears way for forensic auditThe Supreme Court has declined to interfere with Delhi High Court orders in the long-running Daiichi Sankyo-Fortis dispute, allowing a fore...
- Yes Bank moves SC against forensic audit in Fortis share sale issueYes Bank has approached the Supreme Court challenging a recent Delhi High Court directive. The court ordered a forensic audit into the sale...
- Delhi HC orders forensic audit of Fortis, Singh brothers' Rs 4,666-crore trailThe Delhi High Court ordered a forensic audit of Fortis Healthcare transactions. This audit will examine dealings with IHH Healthcare Berha...
- Daiichi-Ranbaxy case: Delhi HC orders forensic audit into transactions of Fortis, Singh brothersThe Delhi High Court has appointed a forensic auditor to examine transactions. This audit aims to trace the dissipation of Fortis Healthcar...
- Delhi HC orders forensic audit of Fortis, IHH and RHT transactions in $4.6-billion Daiichi-Singh caseThe Delhi High Court on Monday ordered the appointment of a forensic auditor to examine transactions involving Fortis Healthcare, Malaysia’...
- Delhi HC set to rule on Daiichi Sankyo arbitration caseThe Delhi High Court is expected to rule this week on Daiichi Sankyo’s long-running arbitration dispute with former Fortis promoters Malvin...
- Sun Pharma’s acquisition: Is this the end of road for the 50-plus-year brand Ranbaxy?Former Ranbaxy officials lament that rival Sun Pharma’s acquisition of the co would mark the death of the brand, which has been ailing for ...
- Sun Pharma-Ranbaxy deal: Daichi Sankyo failed to harness the complexities of a strong generic business, says Malvinder SinghThe Sun-Ranbaxy combined entity will unlock the true potential of the Gurgaon based company, says former Ranbaxy owner Malvinder Singh.
- Sun Pharma to buy Ranbaxy in $3.2 bn deal: HighlightsSun Pharmaceutical Industries said that it will buy generic drug maker Ranbaxy Laboratories, has hit regulatory snags in its key US market ...
- Ranbaxy Q3 top-line seen up 33% at Rs 2698 croreRanbaxy is expected to report a 33 per cent jump in its net sales for the quarter ended September 30 to Rs 2698 crore.
- Ranbaxy launches generic version of Evoxac in US marketRanbaxy has launched generic cevimeline hydrochloride capsules, used in treating Sjogren's syndrome, in the US market.
- Ranbaxy opens new manufacturing facility in Morocco; eyes $1 bn drug marketRanbaxy has opened a new production facility in Morocco, a move which would help the drug maker access the African nation's $1 billion phar...
- Ranbaxy laboratories may hand over Latin American operations to Daiichi SankyoRanbaxy may hand over its L American mkting operations to Daiichi Sankyo, a move could be a precursor to the Indian drugmaker's exit from s...
- Ranbaxy to sell Daiichi Sankyo product in MalaysiaDrug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo today said Ranbaxy will market its parent company's products in Malaysia.
- Ranbaxy: Less aggressive, more Japanese and more healthy after 3 years under Japan's DaiichiUnder Daiichi, Ranbaxy is emerging as a less aggressive, less confrontational, less communicative and more Japanese and more healthy.
- Daiichi to use Ranbaxy network to sell products in SingaporeRanbaxy and Daiichi Sankyo had signed a three-year plan to exploit synergies in operations to enhance their generic as well as branded busi...
- Ranbaxy transfers R&D unit to Daiichi SankyoRanbaxy Laboratories has transferred its research division for new drugs to Japan’s Daiichi Sankyo turning Ranbaxy into a pure generic drug...
- Daiichi's own man to head Ranbaxy qualityJapan's Daiichi Sankyo has named an executive with more than 25 years of experience to oversee the quality and manufacturing standards in R...
Load More
